These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses. Hunt AR; Roehrig JT Vaccine; 1995 Feb; 13(3):281-8. PubMed ID: 7543231 [TBL] [Abstract][Full Text] [Related]
3. The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity. Hunt AR; Frederickson S; Maruyama T; Roehrig JT; Blair CD PLoS Negl Trop Dis; 2010 Jul; 4(7):e739. PubMed ID: 20644615 [TBL] [Abstract][Full Text] [Related]
4. [The antigenic structure of glycoprotein E2 in the Venezuelan equine encephalomyelitis virus studied using rat monoclonal antibodies]. Razumov IA; Agapov EV; Pereboev AV; Protopopova EV; Lebedeva SD; Loktev VB Vopr Virusol; 1991; 36(1):34-7. PubMed ID: 1713372 [TBL] [Abstract][Full Text] [Related]
6. [Monoclonal anti-idiotypic antibodies, imitating the antigenic determinant of hemagglutination site of Venezuelan equine encephalomyelitis virus glycoprotein E2]. Lifke VV; Razumov IA; Konovalova SN Vopr Virusol; 1997; 42(1):19-23. PubMed ID: 9103038 [TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Hunt AR; Johnson AJ; Roehrig JT Virology; 1990 Dec; 179(2):701-11. PubMed ID: 2146802 [TBL] [Abstract][Full Text] [Related]
8. Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III. Phillpotts RJ Virus Res; 2006 Sep; 120(1-2):107-12. PubMed ID: 16621103 [TBL] [Abstract][Full Text] [Related]
9. [The peptide mapping of the E2-2 and E2-6 sites of the E2 glycoprotein in the Venezuelan equine encephalomyelitis virus]. Sviatchenko VA; Pereboev AV; Agapov EV; Razumov IA; Sabirov AN; Mizenko GA; Samukov VV; Loktev VB Vopr Virusol; 1993; 38(4):162-7. PubMed ID: 7694427 [TBL] [Abstract][Full Text] [Related]
10. [The biological and immunochemical properties of monoclonal antibodies to the Venezuelan equine encephalomyelitis virus]. Shpilevaia MV; Tugizov ShM; Kushch AA; Tsilinskiĭ IaIa; Makarova NE Vopr Virusol; 1991; 36(6):495-8. PubMed ID: 1723821 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the hemagglutination activity domains of the Venezuelan equine encephalomyelitis and eastern equine encephalomyelitis viruses. Razumov IA; Khusainova AD; Agapov EV; Gaidamovich SYa ; Pereboev AV; Kolykhalov AA; Netesov SV; Loktev VB Intervirology; 1994; 37(6):356-60. PubMed ID: 8586535 [TBL] [Abstract][Full Text] [Related]
12. [A monoclonal antibody study of the receptor area of the Venezuelan encephalitis virus]. Razumov IA; Pereboev AV; Protopopova EV; Khusainova AD; Agapov EV; Mel'nikova EE; Gaĭdamovich SIa; Loktev VB Vopr Virusol; 1991; 36(6):489-92. PubMed ID: 1723820 [TBL] [Abstract][Full Text] [Related]
14. The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Roehrig JT; Mathews JH Virology; 1985 Apr; 142(2):347-56. PubMed ID: 2414905 [TBL] [Abstract][Full Text] [Related]
15. [Study of the antigenic structure of the E1 glycoprotein of the Venezuelan equine encephalomyelitis virus using monoclonal antibodies]. Razumov IA; Agapov EV; Pereboev AV; Protopopova EV; Lebedeva SD; Loktev VB Mol Gen Mikrobiol Virusol; 1991 Jun; (6):21-4. PubMed ID: 1719387 [TBL] [Abstract][Full Text] [Related]
16. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. Mathews JH; Roehrig JT; Trent DW J Virol; 1985 Sep; 55(3):594-600. PubMed ID: 2410632 [TBL] [Abstract][Full Text] [Related]
17. Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Johnson BJ; Brubaker JR; Roehrig JT; Trent DW Virology; 1990 Aug; 177(2):676-83. PubMed ID: 1695412 [TBL] [Abstract][Full Text] [Related]
18. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus. Bennett AM; Lescott T; Phillpotts RJ Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402 [TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibodies cross-reacting with the tick-borne encephalitis virus and with the Venezuelan equine encephalomyelitis virus]. Gaĭdamovich SIa; Loktev VB; Lavrova NA; Maksiutov AZ; Mel'nikova EE; Pereboev AV; Protopopov EV; Razumov IA; Sveshnikova NA; Khusainova AD Vopr Virusol; 1990; 35(3):221-5. PubMed ID: 1699359 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. Kinney RM; Chang GJ; Tsuchiya KR; Sneider JM; Roehrig JT; Woodward TM; Trent DW J Virol; 1993 Mar; 67(3):1269-77. PubMed ID: 7679745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]